Miami Cancer Institute at Baptist Health — Miami, Florida

Miami Cancer Institute at Baptist Health is a clinical research site located in Miami, Florida, United States 33176.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Miami Cancer Institute at Baptist Health has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Coronavirus Infection, HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer.

Sponsors: Karyopharm Therapeutics Inc, SynDevRx, Inc., InSightec.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Miami Cancer Institute at Baptist Health?

Miami Cancer Institute at Baptist Health has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Miami Cancer Institute at Baptist Health conducted?

Miami Cancer Institute at Baptist Health has 7 clinical trials on record, with 3 currently active. Their work covers Coronavirus Infection, HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer.

Is Miami Cancer Institute at Baptist Health accredited by Crixeo Health?

Yes — Miami Cancer Institute at Baptist Health holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Miami Cancer Institute at Baptist Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.